Sharon Bio-medicine Limited — Loperamide Exporter Profile
Indian Pharmaceutical Exporter · #8 for Loperamide · $2.0M export value · DGFT Verified
Sharon Bio-medicine Limited is the #8 Indian exporter of Loperamide with $2.0M in export value and 82 verified shipments. Sharon Bio-medicine Limited holds a 1.7% market share in Loperamide exports across 3 countries. The company exports 2 pharmaceutical products worth $2.1M across 2 therapeutic categories.
Sharon Bio-medicine Limited — Loperamide Export Profile: Buyers & Destinations
Where Does Sharon Bio-medicine Limited Export Loperamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $573.3K | 41 | 44.5% |
| UNITED KINGDOM | $548.6K | 34 | 42.6% |
| CZECH REPUBLIC | $165.1K | 7 | 12.8% |
Sharon Bio-medicine Limited exports Loperamide to 3 countries. The largest destination is AUSTRALIA accounting for 44.5% of Sharon Bio-medicine Limited's Loperamide shipments, followed by UNITED KINGDOM (42.6%) and CZECH REPUBLIC (12.8%). These destinations reflect Sharon Bio-medicine Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Loperamide from Sharon Bio-medicine Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| OMEGA PHARMA LIMITED | UNITED KINGDOM | $279.9K | 12 |
| ASPEN PHARMACARE AUSTRALIA PTY LTD | AUSTRALIA | $279.8K | 20 |
| GALPHARM INTERNATIONAL LIMITED | UNITED KINGDOM | $268.7K | 22 |
| ASPEN PHARMACARE AUSTRALIA PTY LIMITED | AUSTRALIA | $222.4K | 9 |
| SVUS PHARMA A.S. | CZECH REPUBLIC | $165.1K | 7 |
| C/- LINFOX HEALTHCARE LOGISTICS, 27 | AUSTRALIA | $71.1K | 12 |
Sharon Bio-medicine Limited supplies Loperamide to 6 buyers globally. The largest buyer is OMEGA PHARMA LIMITED (UNITED KINGDOM), followed by ASPEN PHARMACARE AUSTRALIA PTY LTD (AUSTRALIA) and GALPHARM INTERNATIONAL LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Loperamide Export Value and How Much Does Sharon Bio-medicine Limited Contribute?
India exported $23.2M worth of Loperamide through 3,985 shipments from 305 suppliers to 128 countries, serving 1,005 buyers globally. Sharon Bio-medicine Limited contributes $2.0M to this total, accounting for 1.7% of India's Loperamide exports. Sharon Bio-medicine Limited ships Loperamide to 3 countries through 6 buyers.
What Is the Average Shipment Value for Sharon Bio-medicine Limited's Loperamide Exports?
Sharon Bio-medicine Limited's average Loperamide shipment value is $24.0K per consignment, based on 82 shipments totaling $2.0M. The largest destination is AUSTRALIA (44.5% of Sharon Bio-medicine Limited's Loperamide exports).
How Does Sharon Bio-medicine Limited Compare to Other Indian Loperamide Exporters?
Sharon Bio-medicine Limited ranks #8 among 305 Indian Loperamide exporters with a 1.7% market share. The top 3 exporters are TENSHI KAIZEN PRIVATE LIMITED ($4.6M), RUBICON RESEARCH PRIVATE LIMITED ($2.4M), IPCA LABORATORIES LIMITED ($2.1M). Sharon Bio-medicine Limited processed 82 shipments to 3 destination countries.
What Loperamide Formulations Does Sharon Bio-medicine Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LOPERAMIDE 2MG CAPSULES - 01X15000 S, BA | $102.3K | 4 |
| DIARHOEA RELIEF INSTANT 2MG ORODISPERSIBLE TABLETS, (LOPERAMIDE HYDROCHLORIDE 2MG)-GALPHARM SAP: S0103H9, BATCH NO.LPA40 | $95.1K | 6 |
| DIARHOEA RELIEF INSTANT 2MG ORODISPERSIBLE TABLETS, (LOPERAMIDE HYDROCHLORIDE 2MG)- NUMARK SAP: S0040ET, BATCH NO.LPA400 | $78.8K | 6 |
| GASTRO STOP 2MG CAPSULES (OTC)-02X10 S (LOPERAMIDE 2MG CAPSULE) BATCH NO.AKX3016A MFG.DT.07/2023 EXP.DT:06/2025 | $46.0K | 1 |
| GASTRO STOP 2MG CAPSULES (OTC)-02X10 S (LOPERAMIDE 2MG CAPSULE) BATCH NO.AKX3017A MFG.DT.08/2023 EXP.DT:07/2025 | $45.9K | 1 |
| GASTRO STOP 2MG CAPSULES (OTC)-02X10'S,(LOPERAMIDE 2MG CAPSULE), BATCH NO. AKX3028A, MFG.DT.11/2023, EXP.DT:10/2025 | $45.8K | 1 |
| GASTRO STOP 2MG CAPSULES (OTC)-02X10'S,(LOPERAMIDE 2MG CAPSULE), BATCH NO. AKX3027A, MFG.DT.11/2023, EXP.DT:10/2025 | $45.4K | 2 |
| LOPERAMIDE 2MG CAPSULES, BATCH NO. AJW20 | $41.7K | 2 |
| DIARRHOEA RELIEF INSTANT 2MG ORODISPERSIBLE TABLETS(LOPERAMIDE HYDROCHLORIDE 2MG)-GALPHARAM-SAP-5000033161-BT.LPA5003A,* | $40.6K | 1 |
| DIARRHOEA RELIEF INSTANT 2MG ORODISPERSIBLE TABLETS(LOPERAMIDE HYDROCHLORIDE 2MG)-GALPHARAM-SAP-5000033161-BT.LPA5004A, | $40.4K | 1 |
Sharon Bio-medicine Limited exports 45 distinct Loperamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LOPERAMIDE 2MG CAPSULES - 01X15000 S, BA with 4 shipments worth $102.3K.
Regulatory Requirements: Exporting Loperamide to Key Markets
What Sharon Bio-medicine Limited must comply with to export Loperamide to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sharon Bio-medicine Limited Compare to Nearest Loperamide Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | FLAMINGO PHARMACEUTICALS LIMITED | $1.4M | 66 | 4 | $21.7K |
| 7 | AUROBINDO PHARMA LTD | $1.3M | 353 | 4 | $3.8K |
| 8 | SHARON BIO-MEDICINE LIMITED ★ | $1.3M | 82 | 3 | $15.7K |
| 9 | MICRO LABS LIMITED | $1.2M | 57 | 7 | $20.8K |
| 10 | MEDREICH LIMITED | $1.1M | 112 | 2 | $10.3K |
Sharon Bio-medicine Limited ranks #8 among 305 Indian Loperamide exporters. Average shipment value of $15.7K compared to the market average of $76.1K. The closest competitors by value are FLAMINGO PHARMACEUTICALS LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Loperamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 476 | 11.9% |
| SAHAR AIR | 446 | 11.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 436 | 10.9% |
| JNPT/ NHAVA SHEVA SEA | 246 | 6.2% |
| JNPT | 153 | 3.8% |
| BANGALORE ICD (INWFD6) | 150 | 3.8% |
| VIZAG SEA | 115 | 2.9% |
| HYDERABAD AIR | 105 | 2.6% |
About Sharon Bio-medicine Limited
Sharon Bio-medicine Limited exports 2 products worth $2.1M. Beyond Loperamide, top products include Pravastatin. View the complete Sharon Bio-medicine Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Loperamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Loperamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sharon Bio-medicine Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 82 individual customs records matching Sharon Bio-medicine Limited exporting Loperamide, covering 45 formulations to 3 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 128+ countries, 1,005+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Loperamide Export Data from Sharon Bio-medicine Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sharon Bio-medicine Limited's Loperamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sharon Bio-medicine Limited
Full Company Profile →
2 products · $2.1M total trade · 2 categories
Loperamide Stats
Company Overview
Top Products by Sharon Bio-medicine Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sharon Bio-medicine Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Loperamide. For current shipment-level data, contact TransData Nexus.